Construction of a tissue microarray with two millimeters cores of endometrioid endometrial cancer: Factors affecting the quality of the recipient block

Biotechnic and Histochemistry

Volumn 87, Issue 8, 2012, Pages 512-518

  Gottwald, L ^a   Sek P ^b   Piekarski, J ^b   Pasz Walczak, G ^b   Kubiak, R ^b   Szwalski, J ^a,c   Spych, M ^b   Suzin, J ^b   Tylinski W ^b   Topczewska Tylinska, K ^b   Jeziorski, A ^b  

^a POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

^c Histopathology Unit   (Poland)

Author keywords

Donor block; Endometrial cancer; Endometrioid; Recipient block; Tissue microarray

Indexed keywords

PARAFFIN;

ARTICLE; ENDOMETRIUM TUMOR; EVALUATION; FEMALE; HISTOLOGY; HUMAN; INSTRUMENTATION; METHODOLOGY; PATHOLOGY; QUALITY CONTROL; REPRODUCIBILITY; TISSUE MICROARRAY;

ENDOMETRIAL NEOPLASMS; FEMALE; HISTOCYTOLOGICAL PREPARATION TECHNIQUES; HUMANS; PARAFFIN EMBEDDING; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; TISSUE ARRAY ANALYSIS;

EID: 84867546639     PISSN: 10520295     EISSN: 14737760     Source Type: Journal    
DOI: 10.3109/10520295.2012.712160     Document Type: Article

References (30)

1. Camp RL, Charette LA, Rimm DL (2000) Validation of tissue microarray technology in breast carcinoma. Lab. Invest. 80: 1943-1949. (Pubitemid 32012762)
2. Chang E, Lee A, Lee E, Lee H, Shin O, Oh S, Kang C (2004) Her2/neu oncogene amplification by chromogenic in situ hybridization in 130 breast cancers using tissue microarray and clinical follow-up studies. J. Korean Med. Sci. 19: 390-396. (Pubitemid 38859829)
3. Chen W, Foran DJ (2006) Advances in cancer tissue microarray technology: towards improved understanding and diagnostics. Anal. Chim. Acta 564: 74-81.
4. Cimbaluk D, Rotmensch J, Scudiere J, Gown A, Bitterman P (2007) Uterine carcinosarcoma: immunohistochemical studies on tissue microarrays with focus on potential therapeutic targets. Gynecol. Oncol. 105: 138-144. (Pubitemid 46441450)
5. Egervari K, Szollosi Z, Nemes Z (2007) Tissue microarray technology in breast cancer HER2 diagnostics. Pathol. Res. Pract. 203: 169-177.
6. Fergenbaum JH, Garcia-Closas M, Hewitt SM, Lissowska J, Sakoda LC, Sherman ME (2004) Loss of antigenicity in stored sections of breast cancer tissue microarrays. Cancer Epidemiol. Biomark. Prev. 13: 667-672. (Pubitemid 38737907)
7. Fernebro E, Dictor M, Bendahl PO, Fernö M, Nilbert M (2002) Evaluation of the tissue microarray technique for immunohistochemical analysis in rectal cancer. Arch. Pathol. Lab. Med. 126: 702-705. (Pubitemid 34602572)
8. Fowler JM, Ramirez M, Cohn DE, Kelbick N, Pavelka J, Ben-Shachar I, Morrison C (2005) Correlation of cyclooxygenae-2 (COX-2) and aromatase expression in human endometrial cancer: tissue microarray analysis. Am. J. Obstet. Gynecol. 192: 1262-1273. (Pubitemid 40487806)
9. Goldman T, Drömann D, Marzouki M, Schimmel U, Debel K, Branscheid D, Zeiser T, Rupp J, Gerdes J, Zabel P, Vollmer E (2005) Tissue microarrays from HOPE-fixed specimens allow for enhanced high throughput molecular analyses in paraffin-embedded material. Pathol. Res. Pract. 201: 599-602. (Pubitemid 41363955)
10. Gulmann C, Butler D, Kay E, Grace A, Leader M (2003) Biopsy of a biopsy: validation of immunoprofiling in gastric cancer biopsy tissue microarrays. Histopathology 42: 70-76. (Pubitemid 36062570)
11. Gulmann C, O'Grady A (2003) Tissue microarrays: an overview. Curr. Diagn. Pathol. 9: 149-154. (Pubitemid 36541758)
12. Hassan S, Ferrario C, Mamo A, Basik M (2008) Tissue microarrays: emerging standard for biomarker validation. Curr. Opin. Biotechnol. 19: 19-25. (Pubitemid 351226513)
13. Hernandez BY, Frierson HF, Moskaluk CA, Li YJ, Clegg L, Cote TR, McCusker ME, Hankey BF, Edwards BK, Goodman MT (2005) CK20 and CK7 protein expression in colorectal cancer: demonstration of the utility of a population-based tissue microarray. Hum. Pathol. 36: 275-281. (Pubitemid 40404011)
14. Hoos A, Cordon-Cardo C (2001) Tissue microarray profiling of cancer specimens and cell lines: opportunities and limitations. Lab. Invest. 81: 1331-1338. (Pubitemid 32980155)
15. Huang GS, Arend RC, Li M, Gunter MJ, Chiu LG, Horwitz SB, Goldberg GL (2009) Tissue microarray analysis of hormonal signaling pathways in uterine carcinosarcoma. Am. J. Obstet. Gynecol. 200: 457.e1-5.
16. Karnat AA, Younes PS, Sayeeduddin M, Wheeler TM, Simpson JL, Agoulnik AI (2004) Protein expression profiling of endometriosis: validation of 2-tissue microarrays. Fertil. Steril. 82: 1681-1683. (Pubitemid 39611403)
17. Kim JY, Lim SJ, Park K, Lee CM, Kim J (2005) Cyclooxygenase-2 and c-erbB-2 expression in uterine cervical neoplasm assessed using tissue microarrays. Gynecol. Oncol. 97: 337-341. (Pubitemid 40614873)
18. Kononen J, Bubendorf L, Kallioniemi A, Bärlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Med. 4: 844-847. (Pubitemid 28331029)
19. Lugli A, Forster Y, Haas P, Nocito A, Bucher C, Bissig H, Mirlacher M, Storz M, Mihatsch MJ, Sauter G (2003) Calretinin expression in human normal and neoplastic tissues: a tissue microarray analysis on 5233 tissues samples. Hum. Pathol. 34: 994-1000. (Pubitemid 37315250)
20. Mhawech-Faucegllia P, Herrmann FR, Andrews C, South S, Beck A, Lele S, Odunsi K (2009) 14-3-37sigma; Expression and prognostic value in patients with epithelial ovarian carcinoma: a high throughput tissue microarray analysis. EJSO 35: 763-767.
21. Mirlacher M, Simon R (2010) Recipient block in TMA technique. Methods Mol. Biol. 664: 37-44.
22. Mucci NR, Akdas G, Manely S, Rubin MA (2000) Neuroendocrine expression in metastatic prostate cancer: evaluation of high throughput tissue microarrays to detect heterogeneous protein expression. Hum. Pathol. 31: 406-414. (Pubitemid 30262860)
23. Sauter G, Mirlacher M (2002) Tissue microarrays for predictive molecular pathology. J. Clin. Pathol. 55: 575-576.
24. Shergill IS, Shergill NK, Araya M, Patel HR (2004) Tissue microarrays: a current medical research tool. Curr. Med. Res. Opin. 20: 707-712. (Pubitemid 38685016)
25. Simon R, Mirlacher M, Sauter G (2004) Tissue microarrays for early target evaluation. Drug Dis. Today: Technol. 1: 41-48. (Pubitemid 40197551)
26. Takikita M, Chung JY, Hewitt SM (2007) Tissue microarrays enabling high-throughput molecular pathology. Curr. Opin. Biotechnol. 18: 318-325. (Pubitemid 47393621)
27. Tavassoli FA, Devilee P (2003) World Health Organization Classification of Tumors. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. IARC Press, Lyon. pp. 217-258.
28. Tennstedt P, Köster P, Brüchmann A, Mirlacher M, Haese A, Steuber T, Sauter G, Huland H, Graefen M, Schlomm T, Minner S, Simon R (2012) The impact of the number of cores on tissue microarray studies investigating prostate cancer biomarkers. Int. J. Oncol. 40: 261-268.
29. Tzankov A, Went P, Zimpfer A, Dirnhofer S (2005) Tissue microarray technology: principles, pitfalls and perspectives-lessons learned from hematological malignancies. Exp. Gerontol. 40: 737-744. (Pubitemid 41265824)
30. Voduc D, Kenney C, Nielsen TO (2008) Tissue microarrays in clinical oncology. Semin. Radiat. Oncol. 18: 89-97. (Pubitemid 351296453)